Analysis of Trends Over Time of Hepatitis Related Incidence in Panama

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Hepatitis

Treatments: Other: Epidemiologic Surveillance System of the Ministry of Health of Panama

Study type: Observational

Funder types: Industry

Identifiers

NCT01159951

112263

Details and patient eligibility

About

The purpose of this study is to analyze the incidence of baseline hepatitis related outcomes (viral hepatitis A and unspecified viral hepatitis) together with the current frequency of the same outcome after introduction of Havrix™ in Panama.

Full description

In this study, systematic review of the databases of epidemiologic surveillance system (Ministry of Health), for hepatitis related outcomes will be performed. The analysis will be performed by age group, years and country region.

Enrollment: 1 patient

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hepatitis related outcomes occurred during the period analyzed and registered in the Epidemiologic Surveillance System of the Ministry of Health, will be collected for the study

Exclusion criteria

• Not applicable

Trial design

1 participants in 1 patient group

Hepatitis Cohort

Description:

Subjects suffering with hepatitis

Treatment:

Other: Epidemiologic Surveillance System of the Ministry of Health of Panama